Vote Scores

Home / Companies / Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. / 29 Jun 2026

Meeting · year to 30 June 202651 filers reporting

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.: meeting of 29 Jun 2026

Votes reported on Form N-PX, item by item

51 Form N-PX filers reported votes at the Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. meeting of 29 Jun 2026. Their records fall into 5 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

88 vote records from 51 filers. 0 of the 50 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.

98.0% for0.0% against2.0% other0.0% against management51 filers100.0% for0.0% against0.0% against management3,290,376 reported shares
2

EXTRAORDINARY TRANSACTIONSIssuer

EXTRAORDINARY TRANSACTIONS: management items

Management items in this category are shown together; filers word and number them differently.

78 vote records from 41 filers. 29 of the 41 filers that marked the item either way voted against management.

29.3% for70.7% against70.7% against management41 filers48.5% for51.5% against51.5% against management3,176,577 reported shares, counted once per item in this group
3

CAPITAL STRUCTUREIssuer

CAPITAL STRUCTURE: management items

Management items in this category are shown together; filers word and number them differently.

274 vote records from 51 filers. 0 of the 50 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.

90.2% for0.0% against9.8% other0.0% against management51 filers80.7% for19.3% against19.3% against management9,984,927 reported shares, counted once per item in this group
4

CORPORATE GOVERNANCEIssuer

CORPORATE GOVERNANCE: management items

Management items in this category are shown together; filers word and number them differently.

161 vote records from 44 filers. 0 of the 44 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management44 filers100.0% for0.0% against0.0% against management6,511,863 reported shares, counted once per item in this group
5

OTHERIssuer

OTHER: management items

Management items in this category are shown together; filers word and number them differently.

21 vote records from 7 filers. 0 of the 6 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.

85.7% for0.0% against14.3% other0.0% against management7 filers100.0% for0.0% against0.0% against management68,000 reported shares, counted once per item in this group

How the largest families voted

Family1. Auditor
VanguardFor
BlackRock and iSharesFor
FidelityFor
DimensionalFor
State Street and SPDRFor
Franklin TempletonFor
InvescoFor
EquitableFor
Charles SchwabFor
Nuveen and TIAAFor
John Hancock and ManulifeFor
Morgan Stanley, Eaton Vance and CalvertFor
J.P. MorganFor
Goldman SachsFor
WisdomTreeFor
Jackson National fundsFor
Northern Trust and FlexSharesFor
Lincoln FinancialFor
VoyaFor
First TrustFor
BNY MellonFor
Pacific Life fundsFor
Hartford FundsFor

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. meeting?

51 Form N-PX filers reported votes at the meeting of 29 Jun 2026. The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. with a meeting date within three days of 29 Jun 2026. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.